[ad_1]
The obvious question for investors is whether the burst of interest in small-caps presages a longer up-trend for the sector.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...